Mineralys Therapeutics Announces Pricing of $175.0 Million Underwritten Public Offering of ...
BofA Securities, Evercore ISI, Goldman Sachs & Co. LLC, Stifel and Wells Fargo Securities are acting as joint book-running managers for the offering. LifeSci Capital is acting as lead manager and H.C.
The Nassau Guardian22 小时
Chronic kidney disease projected to be 5th leading cause of death in five years
With chronic kidney disease projected to be the fifth leading cause of death by 2040, Nephrologist Dr. Adrian Sawyer is ...